Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
25 participants
OBSERVATIONAL
2012-02-29
2013-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* Provide participating physicians access to specified data sets for the purpose of generating scientific manuscripts about the effects of AeriSeal System treatment.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* AeriSeal System treatment
Exclusion Criteria
* have had frequent COPD exacerbations within the past year
* require mechanical ventilatory support
* have a pretreatment DLCO \< 20% predicted or \> 60% predicted
* have a pretreatment FEV1 \< 20% predicted AND homogeneous emphysema
* have giant bullae
* have undergone lung transplantation, lung volume reduction surgery, or lobectomy
* are intolerant of corticosteroids or antibiotics
* are pregnant or breast-feeding
40 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Aeris Therapeutics
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Janine McDermott, MS CCRP
Role: STUDY_DIRECTOR
Aeris Therapeutics
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Zentralklinik Bad Berka GmbH
Bad Berka, , Germany
Klinikum Coburg
Coburg, , Germany
Klinikum Donaustauf
Donaustauf, , Germany
Asklepios Fachkliniken Muenchen-Gauting
Gauting, , Germany
Universitatsklinikum Halle
Halle, , Germany
Asklepios Klinik Hamburg-Harburg
Hamburg, , Germany
Thoraxklinik am Uniklinikum Heidelberg
Heidelberg, , Germany
Sana Kliniken Luebeck
Lübeck, , Germany
Klinikum Nuerberg Nord
Nuremberg, , Germany
Bethanien KH Solingen
Solingen, , Germany
Soroka Medical Center
Beer Sheeva, , Israel
Rabin Medical Center, Beilinson Campus
Petach Tikvah, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
03-C12-001PLV
Identifier Type: -
Identifier Source: org_study_id